Enable job alerts via email!
A leading viral vector CDMO in Oxford is seeking a Process Compliance Officer to support batch completion and ensure compliance with GMP standards. The ideal candidate will have experience in the pharmaceutical sector, familiarity with CAPAs, and excellent attention to detail. In this role, you will contribute to quality assurance and continuous improvement, working collaboratively with Manufacturing teams. The company offers competitive rewards and a supportive culture.
Join Us in Changing Lives
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
We’re currently recruiting for a Process Compliance Officer to join our Manufacturing team. In this role, you will work alongside the GMP Manufacturing teams to ensure the timely completion of batch-related tasks, playing a key part in advancing our mission and making a real difference.
We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.